Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma
NCT02942693
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Adenoid Cystic Carcinoma
Interventions
DRUG:
Apatinib
RADIATION:
Particle Therapy
Sponsor
Shanghai Proton and Heavy Ion Center